References
- Statista. Number of novel coronavirus (COVID-19) deaths worldwide as of February 14, 2022, by country. Statista Inc. Published February 16, 2022. Updated February 15, 2022. Accessed February 16, 2022. https://www.statista.com/statistics/1093256/novel-coronavirus-2019ncov-deaths-worldwide-by-country/.
- Sharafeldin N, Bates B, Song Q, et al. Outcomes of COVID-19 in patients with cancer: report from the national COVID cohort collaborative (N3C). J Clin Oncol. 2021;39(20):2232–2246. doi:10.1200/JCO.21.01074.
- Tisminetzky M, Delude C, Hebert T, Carr C, Goldberg RJ, Gurwitz JH. Age, multiple chronic conditions, and COVID-19: A literature review. J Gerontol A Biol Sci Med Sci. 2022;77(4):872–878. doi:10.1093/gerona/glaa320.
- Sallam M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi:10.3390/vaccines9020160.
- Uhr L, Mateen FJ. COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey. Mult Scler. 2022;28(7):1072–1080. doi:10.1177/13524585211030647.
- MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036.
- World Health Organization. Top 10 threats to global health in 2019. World Health Organization. Updated January 10, 2019. Accessed October 22, 2021. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
- Larson HJ, Jarrett C, Schulz WS, SAGE Working Group on Vaccine Hesitancy, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine. 2015;33(34):4165–4175. doi:10.1016/j.vaccine.2015.04.037.
- Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020;1–15. doi:10.1017/S0033291720005188.
- Yousefinaghani S, Dara R, Mubareka S, Papadopoulos A, Sharif S. An analysis of COVID-19 vaccine sentiments and opinions on Twitter. Int J Infect Dis. 2021;108:256–262. doi:10.1016/j.ijid.2021.05.059.
- Villarreal-Garza C, Vaca-Cartagena BF, Becerril-Gaitan A, et al. Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol. 2021;7(8):1242–1244. doi:10.1001/jamaoncol.2021.1962.
- Cancer Australia. Frequently Asked Questions about COVID-19 vaccines for people affected by cancer. Cancer Australia. Published December 3, 2021. Accessed December 3, 2021. https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/frequently-asked-questions-about-covid-19-vaccines-people-affected-cancer.
- National Multiple Sclerosis Society. COVID-19 Vaccine Guidance for People Living with MS. National Multiple Sclerosis Society. Accessed December 3, 2021. https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance.
- American Society of Clinical Oncology. Coronavirus and COVID-19: what people with cancer need to know. ASCO: American Society of Clinical Oncology. Accessed December 21, 2021. https://www.cancer.net/blog/2021-12/coronavirus-and-covid-19-what-people-with-cancer-need-know.
- Marsh HW, Morin AJ, Parker PD, Kaur G. Exploratory structural equation modeling: an integration of the best features of exploratory and confirmatory factor analysis. Annu Rev Clin Psychol. 2014;10:85–110. doi:10.1146/annurev-clinpsy-032813-153700.
- Marsh HW, Muthén B, Asparouhov T, et al. Exploratory structural equation modeling, Integrating CFA and EFA: Application to students’evaluations of university teaching. Struct Eq. Model. 2009;16(3):439–476. doi:10.1080/10705510903008220.
- Revelle W. psych: Procedures for psychological, psychometric, and personality research. Northwestern University. https://CRAN.R-project.org/package=psych.
- Muthén LK, Muthén BO. Mplus User’s Guide. 8th ed. Los Angeles: Muthén & Muthén; 2017.
- Osborne JW. Effect sizes and the disattenuation of correlation and regression coefficients: lessons from educational psychology. Pract Assess Res Eval. 8:11.
- Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley and Sons; 2000. p. 160–164.
- Centers for Disease Control and Prevention. Frequently Asked Questions about COVID-19 Vaccination. Centers for Disease Control and Prevention. Accessed December 21, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html.
- Mejri N, Berrazega Y, Ouertani E, et al. Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Support Care Cancer. 2022;30(1):289–293. doi:10.1007/s00520-021-06419-y.
- Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307. doi:10.3389/fpubh.2017.00307.
- Sormani MP, Inglese M, Schiavetti I, et al. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. eBioMed. 2021;72:103581. doi:10.1016/j.ebiom.2021.103581.
- Roeker LE, Knorr DA, Thompson MC, et al. COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Leukemia. 2021;35(9):2703–2705. doi:10.1038/s41375-021-01270-w.
- Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385(24):e84. doi:10.1056/NEJMoa2114583.
- Rubin R. COVID-19 vaccines vs variants-determining how much immunity is enough. JAMA. 2021;325(13):1241–1243. doi:10.1001/jama.2021.3370.
- Diem L, Friedli C, Chan A, Salmen A, Hoepner R. Vaccine hesitancy in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021;8(3):e991. doi:10.1212/NXI.0000000000000991.